(Q51966381)

19 April 2018

title

Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling. (English)

1 reference

19 April 2018

1 reference

1

1 reference

19 April 2018

Benedikt Brors

object named as

Benedikt Brors

9

0 references

Roland Eils

object named as

Roland Eils

11

0 references

Ludger Klein-Hitpass

3

object named as

Ludger Klein-Hitpass

1 reference

19 April 2018

author name string

Johannes H Schulte

2

1 reference

19 April 2018

Werner Havers

4

1 reference

19 April 2018

Hauke Sieverts

5

1 reference

19 April 2018

Bernd Berwanger

6

1 reference

19 April 2018

Holger Christiansen

7

1 reference

19 April 2018

Patrick Warnat

8

1 reference

19 April 2018

Jürgen Eils

10

1 reference

19 April 2018

Angelika Eggert

12

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 November 2005

1 reference

19 April 2018

published in

Oncogene

1 reference

19 April 2018

volume

24

1 reference

19 April 2018

page(s)

7902-7912

1 reference

19 April 2018

issue

53

1 reference

19 April 2018

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208936

exact match

0 references

cites work

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

Expression profiling of favorable and unfavorable neuroblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

Molecular biology of neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

Neuroblastoma Screening at One Year of Age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

Diagnosis of multiple cancer types by shrunken centroids of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

7 January 2021

Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

7 January 2021

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

7 January 2021

The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

7 January 2021

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

7 January 2021

Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

7 January 2021

Expression profiling and characterization of 4200 genes cloned from primary neuroblastomas: identification of 305 genes differentially expressed between favorable and unfavorable subsets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

7 January 2021

Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

7 January 2021

Prediction of central nervous system embryonal tumour outcome based on gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

7 January 2021

CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

7 January 2021

Spontaneous regression of localized neuroblastoma detected by mass screening

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208936

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208936

1 reference

19 April 2018

release_bdc7vetorbhzhicjcvbds46nry

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bdc7vetorbhzhicjcvbds46nry

24 November 2022

mapped directly with Wikidata item

PubMed ID

16103881

1 reference

19 April 2018